449
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients

, , , , , , & show all
Pages 448-457 | Received 19 Sep 2010, Accepted 07 Jan 2011, Published online: 03 Mar 2011

References

  • Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol. 1992;263:E863–9.
  • Gonzalez-Villalobos RA, Seth DM, Satou R, Horton H, Ohashi N, Miyata K, . Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol. 2008;295:F772–9.
  • Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension. 2001;37:1329–35.
  • Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol. 2005; 16:2073–80.
  • Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 2002;61:579–85.
  • Suzaki Y, Ozawa Y, Kobori H. Quantification of human angiotensinogen by a novel sandwich ELISA. Peptides. 2006;27: 3000–2.
  • Katsurada A, Hagiwara Y, Miyashita K, Satou R, Miyata K, Ohashi N, . Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol. 2007;293: F956–60.
  • Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, . Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2:349–54.
  • Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, . Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int. 2003;64:149–59.
  • Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, . Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol. 2009;36:509–15.
  • Kobori H, Katsurada A, Ozawa Y, Satou R, Miyata K, Hase N, . Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun. 2007;358:156–63.
  • Takamatsu M, Urushihara M, Kondo S, Shimizu M, Morioka T, Oite T, . Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol. 2008;23:1257–67.
  • Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension. 2003;41: 42–9.
  • Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, . Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol. 2009;36:750–5.
  • Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension. 2004;43:1126–32.
  • Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, . Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1558–65.
  • Kobori H, , Alper AB JrShenava R, Katsurada A, Saito T, Ohashi N, . Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009;53:344–50.
  • Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, . Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:170–7.
  • Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol. 2007; 292:F330–9.
  • Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8:199–207.
  • Lemley KV, Lafayette RA, Derby G, Blouch KL, Anderson L, Efron B, . Prediction of early progression in recently diagnosed IgA nephropathy. Nephrol Dial Transplant. 2008; 23:213–22.
  • Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009;24:3068–74.
  • Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension. 2003;41:592–7.
  • Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, . Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse. Hypertension. 2002;39:1007–14.
  • Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology. 2002;143:2975–85.
  • Jain S, Li Y, Patil S, Kumar A. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med. 2005;83:121–31.
  • Jain S, Li Y, Patil S, Kumar A. HNF-1alpha plays an important role in IL-6-induced expression of the human angiotensinogen gene. Am J Physiol Cell Physiol. 2007;293: C401–10.
  • Urushihara M, Kondo S, Kagami S, Kobori H. Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am J Nephrol.2010;31:318–25.
  • Ogawa S, Kobori H, Ohashi N, Urushihara M, Nishiyama A, Mori T, . Angiotensin II type 1 receptor blockers reduce urinary angiotensinogen excretion and the levels of urinary markers of oxidative stress and inflammation in patients with type 2 diabetic nephropathy. Biomark Insights. 2009;4:97–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.